March 9, 2022 6:03 AM 3 seconds read

Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY

by Hal Lindon Benzinga Editor
Follow
Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY
Loading...
Loading...
CMMB Logo
CMMBChemomab Therapeutics Ltd
$1.365.43%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
77.94
Price Trend
Short
Medium
Long
Overview
Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Date
▲▼
ticker
▲▼
name
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Click to see more Earnings updates
Posted In:
EarningsNews
Comments

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved